Micrus Endovascular Corporation Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million

Published: May 06, 2010

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq: MEND - News) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.

Back to news